Carol Thomas Daily

Infor appoints Yuka Kanemitsu to lead its Japan unit, a strategic move to capture the nation's burgeoning market for specialized cloud and AI solutions.

X4 Pharmaceuticals secures a key European approval and overhauls its pivotal trial, signaling a major strategic shift backed by a newly extended cash runway.

Beyond a top global ranking, BC Place is leveraging record event growth to drive hundreds of millions in economic impact and redefine Vancouver's world stage.

In an industry first, a data removal service has earned a perfect 5-star PCMag rating, signaling a crucial shift toward continuous, vigilant data protection.

MetLife's fifth 'Pet Insurance of the Year' award isn't just a trophy. It's a signal of a massive cultural and economic shift in how we care for our pets.

With nearly $800M in cash, Immunovant is all-in on a single drug, IMVT-1402. Can its ambitious six-front clinical strategy justify the burn and win the race?

Beyond record revenues, Park-Ohio's Q2 results reveal a strategic pivot, leveraging AI, aerospace, and electrification to forge a less cyclical, high-growth future.

Applied Real Intelligence reports an 18% cash return, trouncing market averages. We dissect the firm's '7S' methodology and its strategic expansion beyond credit.

As record heat stresses backyard pools, a new playbook emerges. We dissect how climate change is forcing an industry to adapt and what it means for homeowners.

As Culver's expands at a breakneck pace, its new partnership with Armada reveals a critical lesson: the future of foodservice is won in the warehouse.

Ad tech firm Shirofune is launching 'Creative Timeline,' a patent-pending AI feature designed to end creative silos and make ad performance data intuitive.

Caitlin Clark and Wilson unveil their third basketball line, a collection that showcases her evolution from star player to product co-creator and brand architect.

As Ascentage Pharma preps its mid-year report, we look beyond the balance sheet at the strategic plays and clinical trials fueling its global oncology ambitions.

XPEL smashes Q2 estimates with record revenue, fueled by explosive China growth. But a costly manufacturing pivot tests its long-term strategy.

Diageo's YunTuo just struck gold, proving China's terroir can produce world-class whisky. A new powerhouse has entered the global spirits game.

Daniela Cavinatto takes the helm at Haleon Canada, bringing a playbook for transformation to a consumer health giant amid a market booming with new trends.

A new oral tablet from Entera Bio could replace painful daily injections for millions with severe osteoporosis, a move validated by a top scientific conference.

A new report reveals businesses are treating energy as a core strategic issue, not a utility bill, as price volatility and soaring demand rewrite the rules.

MGI Tech's strategic alliance with NCSTAR in Queensland is set to accelerate medical breakthroughs by providing a full suite of cutting-edge 'multi-omics' tools.

SentinelOne's new 'governed AI' promises to finally make autonomous security trustworthy. But can it reshape the SOC and win the cyber arms race?